EUCTR2009-012499-28-IT进行中（未招募）不适用
Efficacy of the treatment with hydroxychloroquine in non responders HIV-infected HAART-treated patients - ND
AZIENDA OSPEDALIERA L. SACCO (A.O. DI RILIEVO NAZIONALE)0 个研究点目标入组 40 人开始时间: 2009年8月11日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •18 years of age or older patients, HIV positive with CD4 nadir pre-HAART<100cell/mm3, that meet the definition of INR, with an absolute T CD4+ count less than 200cells/mm3 and an increase in T CD4+ count less than 5% in the previous 6 months despite an effective antiretroviral therapy with NNRTI or bPI +2 NRTI.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Chronic liver disease, cardiopathy, retinopathy, known hypersensitivity to chloroquine and hydroxychloroquine, G6PDH deficit and pregnant and/or nursing women.
研究者
相似试验
进行中（未招募）
不适用
Evaluation of the efficacy of hydroxychloroquine in decreasing immune activation in asymptomatic HIV-infected patients (HCQ-01) - Hydroxychloroquine studyHIV infectionMedDRA version: 9.1Level: LLTClassification code 10020161Term: HIV infectionEUCTR2007-005057-36-GBMedical Research Council
已完成
不适用
HCQ-01 Trial: evaluation of the efficacy of hydroxychloroquine in decreasing immune activation in asymptomatic human immunodeficiency virus (HIV) infected patientsISRCTN30019040Medical Research Council Clinical Trials Unit (MRC CTU) (UK)90
尚未招募
3 期
Efficacy of hydroxychloroquine in graves disease in addition to antithyroid drugs.CTRI/2023/07/054894IPQA laboratories
招募中
3 期
Hydroxychloroquine in comparison with hydroxychloroquine + azithromycin in patients with covid-19COVID-19.U07.1 - COVID-19COVID-19IRCT20200428047228N2Quality Improvement of Intensive Care Research Center- Shahid Beheshti University40
招募中
不适用
Evaluate the efficacy of hydroxychloroquine in the prevention of SARS-COV2 infection in high risk health care workersIRCT20200414047076N1Esfahan University of Medical Sciences160